{"success":true,"data":{"pressRelease":{"id":"147406","rtpr_id":"nPRrI2515a-20260918","ticker":"BIOGW","exchange":"LSE","all_tickers":["BIOGW"],"title":"REG-The Biotech Growth Trust PLC: Net Asset Value(s)","author":"PR Newswire","published_at":"2026-09-18T12:22:10.884Z","article_body":"THE BIOTECH GROWTH TRUST PLC\n\nLEI:549300Z41EP32MI2DN29\n\nNET ASSET VALUE\n\nThe estimated un-audited net asset value per share, calculated in accordance\nwith the guidelines of the Association of Investment Companies, for The\nBiotech Growth Trust PLC at the close of business on 17 September 2026 was\n1753.26p (cum income).\n\nFor and on behalf of the Board\n\nFrostrow Capital LLP\n\nSecretary\n\n18 September 2026\n\n\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nPRrI2515a-20260918","title":"REG-The Biotech Growth Trust PLC: Net Asset Value(s)","author":"PR Newswire","ticker":"BIOGW","created":"2026-09-18T12:22:10.884Z","tickers":["BIOGW"],"exchange":"LSE","article_body":"THE BIOTECH GROWTH TRUST PLC\n\nLEI:549300Z41EP32MI2DN29\n\nNET ASSET VALUE\n\nThe estimated un-audited net asset value per share, calculated in accordance\nwith the guidelines of the Association of Investment Companies, for The\nBiotech Growth Trust PLC at the close of business on 17 September 2026 was\n1753.26p (cum income).\n\nFor and on behalf of the Board\n\nFrostrow Capital LLP\n\nSecretary\n\n18 September 2026\n\n\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved."},"type":"article","timestamp":"2026-09-18T12:22:10.939108032Z","server_sent_at_ms":1789734130939},"received_at":"2026-09-18T12:22:10.989Z","source_url":null},"analysis":{"id":"136209","press_release_id":"147406","analysis_json":{"industry":{"label":"Capital Markets","sector":"Financials"},"redFlags":[],"eventType":"other","narrative":"The estimated un-audited net asset value of The Biotech Growth Trust PLC stood at 1753.26p per share (cum income) at the close of business on 17 September 2026.\n\nThe figure was calculated in line with Association of Investment Companies guidelines and released by Frostrow Capital LLP as secretary on behalf of the board.\n\nThis is routine regulatory boilerplate with no change in strategy, holdings, or outlook; it carries no directional signal for the trust.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Routine NAV disclosure -- suppress from feed; no actionable content."},"keyFigures":{"customDimensions":{"nav_basis":"cum income","nav_audited":false,"nav_valuation_date":"2026-09-17","nav_per_share_pence":1753.26}},"quotedText":"","namedEntities":{"people":[],"products":[],"companies":[{"name":"The Biotech Growth Trust PLC","ticker":"BIOGW","relationship":"filer"},{"name":"Frostrow Capital LLP","relationship":"corporate secretary (issuer of release on behalf of the Board)"},{"name":"Association of Investment Companies","relationship":"industry body whose NAV calculation guidelines were followed"}],"dollarAmounts":[{"amount":"1753.26p","context":"estimated un-audited net asset value per share (cum income) at close of business 17 September 2026"}]},"materialImpact":{"score":1,"reasoning":"Routine periodic NAV disclosure for a UK closed-end investment trust. No earnings, guidance, portfolio action, or directional news -- just the estimated un-audited NAV per share as of the prior close."},"tickerRelevance":{"others":[],"primary":"BIOGW"},"globalImportance":5,"audienceRelevance":5,"eventTypeSecondary":[],"importanceComponents":{"assetClass":"UK listed investment company","tickerTier":"small-cap closed-end trust","eventGravity":"routine-nav-disclosure","issuerAuthored":true,"directionalSignal":"none"}},"event_type":"other","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"The estimated un-audited net asset value of The Biotech Growth Trust PLC stood at 1753.26p per share (cum income) at the close of business on 17 September 2026.\n\nThe figure was calculated in line with Association of Investment Companies guidelines and released by Frostrow Capital LLP as secretary on behalf of the board.\n\nThis is routine regulatory boilerplate with no change in strategy, holdings, or outlook; it carries no directional signal for the trust.","key_figures":{"customDimensions":{"nav_basis":"cum income","nav_audited":false,"nav_valuation_date":"2026-09-17","nav_per_share_pence":1753.26}},"named_entities":{"people":[],"products":[],"companies":[{"name":"The Biotech Growth Trust PLC","ticker":"BIOGW","relationship":"filer"},{"name":"Frostrow Capital LLP","relationship":"corporate secretary (issuer of release on behalf of the Board)"},{"name":"Association of Investment Companies","relationship":"industry body whose NAV calculation guidelines were followed"}],"dollarAmounts":[{"amount":"1753.26p","context":"estimated un-audited net asset value per share (cum income) at close of business 17 September 2026"}]},"model_name":"glm-5.3-flash","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-09-18T12:22:32.663Z","global_importance":5,"audience_relevance":5,"importance_components":{"assetClass":"UK listed investment company","tickerTier":"small-cap closed-end trust","eventGravity":"routine-nav-disclosure","issuerAuthored":true,"directionalSignal":"none"}},"durationMs":21607,"modelName":"glm-5.3-flash"}}